- Home
- SNGX vs BAOS Comparison
SNGX vs BAOS Comparison
Compare SNGX & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- BAOS
- Stock Information
- Founded
- SNGX 1987
- BAOS 2018
- Country
- SNGX United States
- BAOS China
- Employees
- SNGX N/A
- BAOS N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- BAOS Business Services
- Sector
- SNGX Health Care
- BAOS Consumer Discretionary
- Exchange
- SNGX Nasdaq
- BAOS Nasdaq
- Market Cap
- SNGX 7.4M
- BAOS 6.5M
- IPO Year
- SNGX 1987
- BAOS 2021
- Fundamental
- Price
- SNGX $2.39
- BAOS $3.10
- Analyst Decision
- SNGX
- BAOS
- Analyst Count
- SNGX 0
- BAOS 0
- Target Price
- SNGX N/A
- BAOS N/A
- AVG Volume (30 Days)
- SNGX 44.9K
- BAOS 386.9K
- Earning Date
- SNGX 03-14-2025
- BAOS 01-01-0001
- Dividend Yield
- SNGX N/A
- BAOS N/A
- EPS Growth
- SNGX N/A
- BAOS N/A
- EPS
- SNGX N/A
- BAOS N/A
- Revenue
- SNGX $364,183.00
- BAOS $859,226.00
- Revenue This Year
- SNGX N/A
- BAOS N/A
- Revenue Next Year
- SNGX $76.64
- BAOS N/A
- P/E Ratio
- SNGX N/A
- BAOS N/A
- Revenue Growth
- SNGX N/A
- BAOS N/A
- 52 Week Low
- SNGX $1.83
- BAOS $1.44
- 52 Week High
- SNGX $14.88
- BAOS $13.66
- Technical
- Relative Strength Index (RSI)
- SNGX 43.83
- BAOS 47.49
- Support Level
- SNGX $2.25
- BAOS $3.16
- Resistance Level
- SNGX $2.60
- BAOS $3.64
- Average True Range (ATR)
- SNGX 0.15
- BAOS 0.56
- MACD
- SNGX 0.03
- BAOS -0.06
- Stochastic Oscillator
- SNGX 52.27
- BAOS 7.77
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About BAOS Baosheng Media Group Holdings
Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original big data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.